3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
5
Obesity
5
Sexual Infantilism
4
Craniopharyngioma
3
Overweight
2
Weight Loss
1
Pancreatic Neoplasms
1
Insulin Resistance
1
Fatty Liver
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus, Type 1
1
Interventions
Exercise
6
Diet
6
Octreotide
3
Metformin
3
Caloric Restriction
3
Diet, Carbohydrate-Restricted
2
Cognitive Behavioral Therapy
2
sibutramine
1
remune
1
olanzapine-fluoxetine combination
1
irinotecan sucrosofate
1
bermekimab
1
Weight Reduction Programs
1
TOPS
1
Surveys and Questionnaires
1
Sugars
1
Standard of Care
1
Sampling Studies
1
Ritonavir
1
Resistance Training
1
Quality of Life
1
Psychology, Positive
1
Palonosetron
1
Palliative Care
1
Olanzapine
1
Nutritionists
1
Nutritional Status
1
Nutrition Assessment
1
Methods
1
Melatonin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Weight Loss
×
Exenatide
×
Clear all
NCT02664441
2022-05-05
ECHO
Seattle Children's Hospital
Phase 3
Completed
42 enrolled
26 charts